• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SRY相关高迁移率族蛋白5在人类癌症中的生物学功能及治疗潜力

Biological functions and therapeutic potential of SRY related high mobility group box 5 in human cancer.

作者信息

Xue Juan-di, Xiang Wan-Fang, Cai Ming-Qin, Lv Xiao-Yun

机构信息

The School of Basic Medicine Sciences of Lanzhou University, Lanzhou, China.

School/Hospital of Stomatology of Lanzhou University, Lanzhou, China.

出版信息

Front Oncol. 2024 May 21;14:1332148. doi: 10.3389/fonc.2024.1332148. eCollection 2024.

DOI:10.3389/fonc.2024.1332148
PMID:38835366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11148273/
Abstract

Cancer is a heavy human burden worldwide, with high morbidity and mortality. Identification of novel cancer diagnostic and prognostic biomarkers is important for developing cancer treatment strategies and reducing mortality. Transcription factors, including SRY associated high mobility group box (SOX) proteins, are thought to be involved in the regulation of specific biological processes. There is growing evidence that SOX transcription factors play an important role in cancer progression, including tumorigenesis, changes in the tumor microenvironment, and metastasis. SOX5 is a member of SOX Group D of Sox family. SOX5 is expressed in various tissues of human body and participates in various physiological and pathological processes and various cellular processes. However, the abnormal expression of SOX5 is associated with cancer of various systems, and the abnormal expression of SOX5 acts as a tumor promoter to promote cancer cell viability, proliferation, invasion, migration and EMT through multiple mechanisms. In addition, the expression pattern of SOX5 is closely related to cancer type, stage and adverse clinical outcome. Therefore, SOX5 is considered as a potential biomarker for cancer diagnosis and prognosis. In this review, the expression of SOX5 in various human cancers, the mechanism of action and potential clinical significance of SOX5 in tumor, and the therapeutic significance of Sox5 targeting in cancer were reviewed. In order to provide a new theoretical basis for cancer clinical molecular diagnosis, molecular targeted therapy and scientific research.

摘要

癌症是全球沉重的人类负担,发病率和死亡率都很高。鉴定新型癌症诊断和预后生物标志物对于制定癌症治疗策略和降低死亡率至关重要。转录因子,包括SRY相关高迁移率族框(SOX)蛋白,被认为参与特定生物学过程的调控。越来越多的证据表明,SOX转录因子在癌症进展中发挥重要作用,包括肿瘤发生、肿瘤微环境变化和转移。SOX5是Sox家族D组的成员。SOX5在人体各种组织中表达,并参与各种生理和病理过程以及各种细胞过程。然而,SOX5的异常表达与各种系统的癌症相关,并且SOX5的异常表达通过多种机制作为肿瘤促进剂促进癌细胞的存活、增殖、侵袭、迁移和上皮-间质转化。此外,SOX5的表达模式与癌症类型、分期和不良临床结局密切相关。因此,SOX5被认为是癌症诊断和预后的潜在生物标志物。在本综述中,对SOX5在各种人类癌症中的表达、SOX5在肿瘤中的作用机制和潜在临床意义以及靶向Sox5在癌症中的治疗意义进行了综述。以便为癌症临床分子诊断、分子靶向治疗及科研提供新的理论依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbf/11148273/4f1ba3ab3b1f/fonc-14-1332148-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbf/11148273/82bb7533737e/fonc-14-1332148-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbf/11148273/4dff714d15bf/fonc-14-1332148-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbf/11148273/4f1ba3ab3b1f/fonc-14-1332148-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbf/11148273/82bb7533737e/fonc-14-1332148-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbf/11148273/4dff714d15bf/fonc-14-1332148-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddbf/11148273/4f1ba3ab3b1f/fonc-14-1332148-g003.jpg

相似文献

1
Biological functions and therapeutic potential of SRY related high mobility group box 5 in human cancer.SRY相关高迁移率族蛋白5在人类癌症中的生物学功能及治疗潜力
Front Oncol. 2024 May 21;14:1332148. doi: 10.3389/fonc.2024.1332148. eCollection 2024.
2
The role of SOX family members in solid tumours and metastasis.SOX 家族成员在实体瘤和转移中的作用。
Semin Cancer Biol. 2020 Dec;67(Pt 1):122-153. doi: 10.1016/j.semcancer.2019.03.004. Epub 2019 Mar 23.
3
Cloning and characterization of SOX5, a new member of the human SOX gene family.人类SOX基因家族新成员SOX5的克隆与特性分析
Genomics. 1996 Sep 1;36(2):354-8. doi: 10.1006/geno.1996.0474.
4
Identification and characterization of the human long form of Sox5 (L-SOX5) gene.人类长型Sox5(L-SOX5)基因的鉴定与表征
Gene. 2002 Sep 18;298(1):59-68. doi: 10.1016/s0378-1119(02)00927-7.
5
Integrative analysis of the SOX family-related prognostic signature and immunological infiltration in prostate cancer.前列腺癌中SOX家族相关预后特征与免疫浸润的综合分析
Transl Cancer Res. 2023 Aug 31;12(8):2048-2062. doi: 10.21037/tcr-23-501. Epub 2023 Aug 28.
6
Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1.Sox5 通过转录激活 Twist1 诱导上皮间质转化。
Biochem Biophys Res Commun. 2014 Mar 28;446(1):322-7. doi: 10.1016/j.bbrc.2014.02.109. Epub 2014 Mar 4.
7
SOX5 interacts with YAP1 to drive malignant potential of non-small cell lung cancer cells.SOX5与YAP1相互作用以驱动非小细胞肺癌细胞的恶性潜能。
Am J Cancer Res. 2018 May 1;8(5):866-878. eCollection 2018.
8
Novel role of the SRY-related high-mobility-group box D gene in cancer.SRY 相关高迁移率族盒 D 基因在癌症中的新作用。
Semin Cancer Biol. 2020 Dec;67(Pt 1):83-90. doi: 10.1016/j.semcancer.2019.07.011. Epub 2019 Jul 26.
9
Biological functions and therapeutic potential of CKS2 in human cancer.CKS2在人类癌症中的生物学功能及治疗潜力
Front Oncol. 2024 Aug 12;14:1424569. doi: 10.3389/fonc.2024.1424569. eCollection 2024.
10
SOX5 promotes cell invasion and metastasis via activation of Twist-mediated epithelial-mesenchymal transition in gastric cancer.SOX5通过激活Twist介导的胃癌上皮-间质转化促进细胞侵袭和转移。
Onco Targets Ther. 2019 Apr 3;12:2465-2476. doi: 10.2147/OTT.S197087. eCollection 2019.

引用本文的文献

1
The SOX gene superfamily in oncogenesis: unraveling links to ncRNAs, key pathways, chemoresistance, and gene editing approaches.SOX基因超家族在肿瘤发生中的作用:揭示与非编码RNA、关键信号通路、化疗耐药性及基因编辑方法的联系
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 20. doi: 10.1007/s00210-025-04229-1.
2
The long noncoding RNA MIR4435-2HG enhances the migration, promotion, and glycolysis of nonsmall cell lung cancer cells by targeting the miR-371a-5p/SOX2/PI3K/Akt axis.长链非编码RNA MIR4435-2HG通过靶向miR-371a-5p/SOX2/PI3K/Akt轴增强非小细胞肺癌细胞的迁移、增殖和糖酵解。
SAGE Open Med. 2024 Nov 8;12:20503121241289290. doi: 10.1177/20503121241289290. eCollection 2024.

本文引用的文献

1
EGR1//SOX5 axis modulates migration, invasion and Gemcitabine resistance of bladder cancer cells.EGR1//SOX5 轴调节膀胱癌细胞的迁移、侵袭和吉西他滨耐药性。
Cancer Biol Ther. 2023 Dec 31;24(1):2270106. doi: 10.1080/15384047.2023.2270106. Epub 2023 Oct 20.
2
Integrative analysis of the SOX family-related prognostic signature and immunological infiltration in prostate cancer.前列腺癌中SOX家族相关预后特征与免疫浸润的综合分析
Transl Cancer Res. 2023 Aug 31;12(8):2048-2062. doi: 10.21037/tcr-23-501. Epub 2023 Aug 28.
3
Genomic and evolutionary characteristics of metastatic gastric cancer by routes.
通过途径分析转移性胃癌的基因组和进化特征。
Br J Cancer. 2023 Sep;129(4):672-682. doi: 10.1038/s41416-023-02338-3. Epub 2023 Jul 8.
4
CircWHSC1 serves as a prognostic biomarker and promotes malignant progression of non-small-cell lung cancer via miR-590-5p/SOX5 axis.环状 WHSC1 作为一种预后生物标志物,通过 miR-590-5p/SOX5 轴促进非小细胞肺癌的恶性进展。
Environ Toxicol. 2023 Oct;38(10):2440-2449. doi: 10.1002/tox.23879. Epub 2023 Jul 7.
5
SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway.SALL4 通过影响 MAPK 通路与前列腺癌的增殖、转移和不良预后相关。
Cancer Med. 2023 Jun;12(12):13471-13485. doi: 10.1002/cam4.5998. Epub 2023 Apr 29.
6
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth.不断演变的肿瘤微环境:从癌症起始到转移灶生长
Cancer Cell. 2023 Mar 13;41(3):374-403. doi: 10.1016/j.ccell.2023.02.016.
7
Cisplatin in cancer treatment.顺铂在癌症治疗中的应用。
Biochem Pharmacol. 2022 Dec;206:115323. doi: 10.1016/j.bcp.2022.115323. Epub 2022 Nov 8.
8
Current best practice for bladder cancer: a narrative review of diagnostics and treatments.当前膀胱癌的最佳实践:诊断和治疗的叙述性综述。
Lancet. 2022 Nov 12;400(10364):1712-1721. doi: 10.1016/S0140-6736(22)01188-6. Epub 2022 Sep 26.
9
Curcumin in the treatment of urological cancers: Therapeutic targets, challenges and prospects.姜黄素在泌尿系统癌症治疗中的应用:治疗靶点、挑战与展望。
Life Sci. 2022 Nov 15;309:120984. doi: 10.1016/j.lfs.2022.120984. Epub 2022 Sep 20.
10
circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition.circ-LDLRAD3 通过 miR-588 富集介导的 SOX5 抑制降低顺铂耐药性并抑制顺铂耐药性胃癌的发展。
Gut Liver. 2023 May 15;17(3):389-403. doi: 10.5009/gnl210195. Epub 2022 Aug 17.